Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
|Slideshows|August 9, 2011
Transvaginal Sonography and Endometrium
Author(s)Galal Lotfi, MD, MRCOG
Presentation by Galal Lotfi, MD, MRCOG, professor of obstetrics and gynecology for Suez Canal University in Egypt.
Advertisement
Advertisement
Related to this article
Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
How estrogen-centered menopause care sidelined testosterone in women
2
Testosterone for women: Global consensus and physiologic dosing
3
What biomarker-guided preeclampsia care could look like
4
Testosterone physiology in women and the long road to approval
5